 | Up a level |
Zettl, Uwe Klaus; Rommer, Paulus Stefan; Aktas, Orhan; Wagner, Torsten; Richter, Joachim; Oschmann, Patrick; Cepek, Lukas; Elias-Hamp, Birte; Gehring, Klaus; Chan, Andrew; Hecker, Michael (2023). Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation. Expert review of clinical immunology, 19(11), pp. 1343-1359. Taylor & Francis 10.1080/1744666X.2023.2248391
Goßrau, Gudrun; Förderreuther, Stefanie; Ruscheweyh, Ruth; Ruschil, Victoria; Sprenger, Till; Lewis, David; Kamm, Katharina; Freilinger, Tobias; Neeb, Lars; Malzacher, Volker; Meier, Uwe; Gehring, Klaus; Kraya, Torsten; Dresler, Thomas; Schankin, Christoph J; Gantenbein, Andreas R; Brössner, Gregor; Zebenholzer, Karin; Diener, Hans-Christoph; Gaul, Charly; ... (2023). [Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. Der Nervenarzt, 94(4), pp. 306-317. Springer 10.1007/s00115-022-01403-1
Goßrau, Gudrun; Förderreuther, Stefanie; Ruscheweyh, Ruth; Ruschil, Victoria; Sprenger, Till; Lewis, David; Kamm, Katharina; Freilinger, Tobias; Neeb, Lars; Malzacher, Volker; Meier, Uwe; Gehring, Klaus; Kraya, Torsten; Dresler, Thomas; Schankin, Christoph J; Gantenbein, Andreas R; Brössner, Gregor; Zebenholzer, Karin; Diener, Hans-Christoph; Gaul, Charly; ... (2023). [Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. Der Nervenarzt, 94(4), pp. 318-319. Springer 10.1007/s00115-022-01435-7
Goßrau, Gudrun; Förderreuther, Stefanie; Ruscheweyh, Ruth; Ruschil, Victoria; Sprenger, Till; Lewis, David; Kamm, Katharina; Freilinger, Tobias; Neeb, Lars; Malzacher, Volker; Meier, Uwe; Gehring, Klaus; Kraya, Torsten; Dresler, Thomas; Schankin, Christoph J; Gantenbein, Andreas R; Brössner, Gregor; Zebenholzer, Karin; Diener, Hans-Christoph; Gaul, Charly; ... (2023). [Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. Der Schmerz, 37(1), pp. 5-16. Springer 10.1007/s00482-022-00671-9
Goßrau, Gudrun; Förderreuther, Stefanie; Ruscheweyh, Ruth; Ruschil, Victoria; Sprenger, Till; Lewis, David; Kamm, Katharina; Freilinger, Tobias; Neeb, Lars; Malzacher, Volker; Meier, Uwe; Gehring, Klaus; Kraya, Torsten; Dresler, Thomas; Schankin, Christoph J; Gantenbein, Andreas R; Brössner, Gregor; Zebenholzer, Karin; Diener, Hans-Christoph; Gaul, Charly; ... (2023). [Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. Schmerz, 37(1), pp. 17-18. Springer 10.1007/s00482-022-00691-5
Wiendl, Heinz; Gold, Ralf; Berger, Thomas; Derfuss, Tobias; Linker, Ralf; Mäurer, Mathias; Stangel, Martin; Aktas, Orhan; Baum, Karl; Berghoff, Martin; Bittner, Stefan; Chan, Andrew Hao-Kuang; Czaplinski, Adam; Deisenhammer, Florian; Di Pauli, Franziska; Du Pasquier, Renaud; Enzinger, Christian; Fertl, Elisabeth; Gass, Achim; Gehring, Klaus; ... (2021). [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. Der Nervenarzt, 92(8), pp. 773-801. Springer 10.1007/s00115-021-01157-2
Wiendl, Heinz; Gold, Ralf; Berger, Thomas; Derfuss, Tobias; Linker, Ralf; Mäurer, Mathias; Aktas, Orhan; Baum, Karl; Berghoff, Martin; Bittner, Stefan; Chan, Andrew; Czaplinski, Adam; Deisenhammer, Florian; Di Pauli, Franziska; Du Pasquier, Renaud; Enzinger, Christian; Fertl, Elisabeth; Gass, Achim; Gehring, Klaus; Gobbi, Claudio; ... (2021). Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic advances in neurological disorders, 14, p. 17562864211039648. Sage 10.1177/17562864211039648
